-
1
-
-
84878490313
-
A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia
-
Francis S, Lucas CM, Wang L, et al. A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia. Leuk Res 2013;37:752-8.
-
(2013)
Leuk Res
, vol.37
, pp. 752-758
-
-
Francis, S.1
Lucas, C.M.2
Wang, L.3
-
2
-
-
78650676294
-
EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors
-
Daghistani M, Marin D, Khorashad JS, et al. EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors. Blood 2010;116:6014-7.
-
(2010)
Blood
, vol.116
, pp. 6014-6017
-
-
Daghistani, M.1
Marin, D.2
Khorashad, J.S.3
-
3
-
-
38349193809
-
Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia
-
Wang L, Giannoudis A, Lane S, et al. Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia. Clin Pharmacol Ther 2008;83:258-64.
-
(2008)
Clin Pharmacol Ther
, vol.83
, pp. 258-264
-
-
Wang, L.1
Giannoudis, A.2
Lane, S.3
-
4
-
-
37049028176
-
Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity
-
White DL, Saunders VA, Dang P, et al. Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity. Blood 2007;110:4064-72.
-
(2007)
Blood
, vol.110
, pp. 4064-4072
-
-
White, D.L.1
Saunders, V.A.2
Dang, P.3
-
5
-
-
1842717950
-
Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome
-
Zhang Z, Burch P, Cooney A, et al. Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome. Genome Res 2004;14:580-90.
-
(2004)
Genome Res
, vol.14
, pp. 580-590
-
-
Zhang, Z.1
Burch, P.2
Cooney, A.3
-
6
-
-
84866319957
-
Peroxisome proliferator-activated receptor activation increases imatinib uptake and killing of chronic myeloid leukemia cells
-
Wang L, Giannoudis A, Austin G, et al. Peroxisome proliferator-activated receptor activation increases imatinib uptake and killing of chronic myeloid leukemia cells. Exp Hematol 2012;40:811-9.
-
(2012)
Exp Hematol
, vol.40
, pp. 811-819
-
-
Wang, L.1
Giannoudis, A.2
Austin, G.3
-
7
-
-
9444282642
-
Active transport of imatinib into and out of cells: implications for drug resistance
-
Thomas J, Wang L, Clark R, et al. Active transport of imatinib into and out of cells: implications for drug resistance. Blood 2004;104:3739-45.
-
(2004)
Blood
, vol.104
, pp. 3739-3745
-
-
Thomas, J.1
Wang, L.2
Clark, R.3
-
8
-
-
0038000046
-
The nuclear pregnane X receptor regulates xenobiotic detoxification
-
Kliewer SA. The nuclear pregnane X receptor regulates xenobiotic detoxification. J Nutr 2003;133:2444S-7S.
-
(2003)
J Nutr
, vol.133
, pp. 2444S-2447S
-
-
Kliewer, S.A.1
-
9
-
-
34548059857
-
Effect of pregnane X receptor ligand on pharmacokinetics of substrates of organic cation transporter Oct1 in rats
-
Maeda T, Oyabu M, Yotsumoto T, et al. Effect of pregnane X receptor ligand on pharmacokinetics of substrates of organic cation transporter Oct1 in rats. Drug Metab Dispos 2007;35:1580-6.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 1580-1586
-
-
Maeda, T.1
Oyabu, M.2
Yotsumoto, T.3
-
10
-
-
59149090185
-
Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor
-
Köhle C, Bock KW. Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. Biochem Pharmacol 2009;77:689-99.
-
(2009)
Biochem Pharmacol
, vol.77
, pp. 689-699
-
-
Köhle, C.1
Bock, K.W.2
-
11
-
-
79951812086
-
Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants
-
Cho SK, Yoon JS, Lee MG, et al. Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants. Clin Pharmacol Ther 2011;89:416-21.
-
(2011)
Clin Pharmacol Ther
, vol.89
, pp. 416-421
-
-
Cho, S.K.1
Yoon, J.S.2
Lee, M.G.3
-
12
-
-
34548350509
-
Discovery of a highly active ligand of human pregnane x receptor: a case study from pharmacophore modeling and virtual screening to "in vivo" biological activity
-
Lemaire G, Benod C, Nahoum V, et al. Discovery of a highly active ligand of human pregnane x receptor: a case study from pharmacophore modeling and virtual screening to "in vivo" biological activity. Mol Pharmacol 2007;723:572-81.
-
(2007)
Mol Pharmacol
, vol.723
, pp. 572-581
-
-
Lemaire, G.1
Benod, C.2
Nahoum, V.3
-
14
-
-
84873744673
-
Differential regulation of drug transporter expression by all-trans retinoic acid in hepatoma HepaRG cells and human hepatocytes
-
Le Vee M, Jouan E, Stieger B, et al. Differential regulation of drug transporter expression by all-trans retinoic acid in hepatoma HepaRG cells and human hepatocytes. Eur J Pharm Sci 2013;48:767-74.
-
(2013)
Eur J Pharm Sci
, vol.48
, pp. 767-774
-
-
Le Vee, M.1
Jouan, E.2
Stieger, B.3
-
15
-
-
84865555252
-
Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation
-
Gocek E, Marchwicka A, Baurska H, et al. Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation. J Steroid Biochem Mol Biol 2012;132:220-6.
-
(2012)
J Steroid Biochem Mol Biol
, vol.132
, pp. 220-226
-
-
Gocek, E.1
Marchwicka, A.2
Baurska, H.3
-
17
-
-
0037443754
-
MDR1 gene overexpression confers resistance to imatinibmesylate in leukemia cell line models
-
Mahon FX, Belloc F, Lagarde V, et al. MDR1 gene overexpression confers resistance to imatinibmesylate in leukemia cell line models. Blood 2003;101:2368-73.
-
(2003)
Blood
, vol.101
, pp. 2368-2373
-
-
Mahon, F.X.1
Belloc, F.2
Lagarde, V.3
-
18
-
-
0442313672
-
Effect of rifampicin on the pharmacokinetics of imatinibmesylate (Gleevec, STI571) in healthy subjects
-
Bolton AE, Peng B, Hubert M, et al. Effect of rifampicin on the pharmacokinetics of imatinibmesylate (Gleevec, STI571) in healthy subjects. Cancer Chemother Pharmacol 2004;53:102-6.
-
(2004)
Cancer Chemother Pharmacol
, vol.53
, pp. 102-106
-
-
Bolton, A.E.1
Peng, B.2
Hubert, M.3
-
19
-
-
35948961894
-
Human pregnane X receptor and resistance to chemotherapy in prostate cancer
-
Chen Y, Tang Y, Wang MT, et al. Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Cancer Res 2007;67:10361-7.
-
(2007)
Cancer Res
, vol.67
, pp. 10361-10367
-
-
Chen, Y.1
Tang, Y.2
Wang, M.T.3
|